Predictive Utility of Diffusion MRI After Mild Traumatic Brain Injury in Civilian Populations: A Systematic Review

Sanne van Rhijn1, Maria Teixeira-Dias1, Nick Medford1

  • 1Department of Neuropsychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London (all authors); Perinatal Mental Health Service, West London National Health Service Trust, London (van Rhijn).

Abstract

Insights

Subtle white matter changes may explain persistent symptoms after mild traumatic brain injury (mTBI). Advanced MRI shows links between white matter integrity and cognitive deficits or postconcussive symptoms months after uncomplicated mTBI.

Area of Science:

  • Neuroscience
  • Radiology
  • Neurology

Background:

  • Persistent symptoms and functional limitations are common after mild traumatic brain injury (mTBI).
  • The role of subtle white matter changes in these long-term effects remains unclear.
  • This review focuses on uncomplicated mTBI, excluding blast, sports-related, or multiple injuries.

Approach:

  • Systematic review of advanced MRI techniques, including Diffusion Tensor Imaging (DTI) and Susceptibility-Weighted Imaging (SWI).
  • Extracted microstructural white matter indices and clinical outcomes (cognitive, neuropsychiatric, functional) from 13 studies.
  • Included studies with uncomplicated mTBI patients and healthy controls, excluding specific injury types.

Key Points:

  • Five of seven DTI studies found correlations between reduced white matter integrity and cognitive deficits (attention, processing speed, executive function) 6-12 months post-injury.
  • Four studies linked DTI metrics to persistent postconcussive symptoms 3-12 months after injury.
  • Two SWI studies showed conflicting results regarding microbleeds and symptom persistence.

Conclusions:

  • Microstructural white matter integrity may correlate with clinical presentation 3-12 months after uncomplicated mTBI.
  • Variability in analysis methods and brain regions studied necessitates further research.
  • Future studies should investigate regional white matter indices and symptom persistence beyond 12 months.